Ending Chemical Abortions Act of 2025

# Ending Chemical Abortions Act of 2025 (HR 629) Summary **What the Bill Would Do** This bill would restrict medication abortion by reclassifying mifepristone (a drug used in medication abortions) under federal law in a way that could limit its availability and use. The bill also contains provisions related to criminal investigation and prosecution procedures, though the specific enforcement mechanisms are not detailed in the available summary information. **Who It Affects** The bill would directly impact women seeking medication abortion, healthcare providers who prescribe these medications, and pharmaceutical companies. It could also affect state-level abortion regulations, as states have varying laws regarding medication abortion access. **Current Status** The bill was introduced in the 119th Congress by Representative Andrew Ogles (R-TN) and is currently in committee, meaning it has not yet been debated or voted on by the full House.

It remains in the early stages of the legislative process. To get more detailed information about specific provisions, you can review the full text on Congress.gov.